A Comprehensive Review on the Effect of an Ayurvedic Protocol in Metabolic Syndrome

Harishma Asok.S, Arjun Chand. C.P, Arun Pratap, Kasthuri Nair.A
{"title":"A Comprehensive Review on the Effect of an Ayurvedic Protocol in Metabolic Syndrome","authors":"Harishma Asok.S, Arjun Chand. C.P, Arun Pratap, Kasthuri Nair.A","doi":"10.47070/ijapr.v12i2.3144","DOIUrl":null,"url":null,"abstract":"The clustering of obesity, dyslipidaemia, impaired glucose tolerance, and hypertension, known as 'Metabolic Syndrome (MS),' has emerged as a significant global public health and clinical concern, attributed to urbanization, sedentary lifestyles, and dietary shifts. Metabolic Syndrome aligns well with the Ayurvedic concept of Medodhatuvriddhi, Medovahasrothodushti, Santharpanajanya vikaras (Sthoulya, Medoroga, Prameha, Hrdroga) and Ama pradoshaja vikaras. It is primarily caused by the vitiation of Kapha, Meda, Ama and hence drugs having Kaphavatahara, Medohara Chikitsa should be mainly adopted. Additionally, there is a common misconception among the public that ghee consumption leads to hyperlipidaemia. Taking these factors into account, a protocol has been formulated to assess the effectiveness of Huthabhugadi churna and Trayushnadi ghrtam in the management of MS. Most of the drugs in the formulations are having Kapha vatahara and Medohara properties which might help in eliminating excess Medodhathu and promote optimal Rasadi dhathus. Huthabhugadi Churna might play a pivotal role in addressing Jatharagnimandya whereas Trayushnadi Ghrtam might correct the imbalance in Dhatvagnimandya reducing the Atipravritti of Medodhathu. Consequently, this protocol might effectively help in reducing Kapha, meda and ama ultimately alleviating the symptoms associated with MS.","PeriodicalId":13913,"journal":{"name":"International Journal of Ayurveda and Pharma Research","volume":"358 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Ayurveda and Pharma Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47070/ijapr.v12i2.3144","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The clustering of obesity, dyslipidaemia, impaired glucose tolerance, and hypertension, known as 'Metabolic Syndrome (MS),' has emerged as a significant global public health and clinical concern, attributed to urbanization, sedentary lifestyles, and dietary shifts. Metabolic Syndrome aligns well with the Ayurvedic concept of Medodhatuvriddhi, Medovahasrothodushti, Santharpanajanya vikaras (Sthoulya, Medoroga, Prameha, Hrdroga) and Ama pradoshaja vikaras. It is primarily caused by the vitiation of Kapha, Meda, Ama and hence drugs having Kaphavatahara, Medohara Chikitsa should be mainly adopted. Additionally, there is a common misconception among the public that ghee consumption leads to hyperlipidaemia. Taking these factors into account, a protocol has been formulated to assess the effectiveness of Huthabhugadi churna and Trayushnadi ghrtam in the management of MS. Most of the drugs in the formulations are having Kapha vatahara and Medohara properties which might help in eliminating excess Medodhathu and promote optimal Rasadi dhathus. Huthabhugadi Churna might play a pivotal role in addressing Jatharagnimandya whereas Trayushnadi Ghrtam might correct the imbalance in Dhatvagnimandya reducing the Atipravritti of Medodhathu. Consequently, this protocol might effectively help in reducing Kapha, meda and ama ultimately alleviating the symptoms associated with MS.
综合评述阿育吠陀疗法对代谢综合征的影响
肥胖症、血脂异常、糖耐量减低和高血压的聚集称为 "代谢综合征(MS)",已成为全球公共卫生和临床上的一个重大问题,其原因在于城市化、久坐不动的生活方式和饮食结构的改变。代谢综合征与阿育吠陀医学的 Medodhatuvriddhi、Medovahasrothodushti、Santharpanajanya vikaras(Sthoulya、Medoroga、Prameha、Hrdroga)和 Ama pradoshaja vikaras 概念十分吻合。它主要是由 Kapha、Meda、Ama 败坏引起的,因此应主要采用具有 Kaphavatahara、Medohara Chikitsa 的药物。此外,公众普遍误认为食用酥油会导致高脂血症。考虑到这些因素,我们制定了一个方案来评估 Huthabhugadi churna 和 Trayushnadi ghrtam 在治疗多发性硬化症方面的效果。配方中的大多数药物都具有 Kapha vatahara 和 Medohara 特性,这可能有助于消除多余的 Medodhathu,促进 Rasadi dhathus 的优化。Huthabhugadi Churna 可在解决 Jatharagnimandya 方面发挥关键作用,而 Trayushnadi Ghrtam 则可纠正 Dhatvagnimandya 的失衡,减少 Medodhathu 的 Atipravritti。因此,该方案可有效帮助减少卡帕、meda 和 ama,最终缓解多发性硬化症的相关症状。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信